DK2398818T3 - Midler til oprensning af et blodplasmaprotein og fremgangsmåder til gennemførelse heraf - Google Patents
Midler til oprensning af et blodplasmaprotein og fremgangsmåder til gennemførelse heraf Download PDFInfo
- Publication number
- DK2398818T3 DK2398818T3 DK10709893.1T DK10709893T DK2398818T3 DK 2398818 T3 DK2398818 T3 DK 2398818T3 DK 10709893 T DK10709893 T DK 10709893T DK 2398818 T3 DK2398818 T3 DK 2398818T3
- Authority
- DK
- Denmark
- Prior art keywords
- purification
- procedures
- agents
- implementation
- blood plasma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0951083A FR2942233B1 (fr) | 2009-02-19 | 2009-02-19 | Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre |
| PCT/FR2010/050294 WO2010094901A1 (fr) | 2009-02-19 | 2010-02-19 | Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en œuvre |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2398818T3 true DK2398818T3 (da) | 2019-01-02 |
Family
ID=41319742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10709893.1T DK2398818T3 (da) | 2009-02-19 | 2010-02-19 | Midler til oprensning af et blodplasmaprotein og fremgangsmåder til gennemførelse heraf |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9534012B2 (da) |
| EP (1) | EP2398818B1 (da) |
| JP (2) | JP6129473B2 (da) |
| KR (1) | KR101713761B1 (da) |
| CN (1) | CN102405228B (da) |
| AU (1) | AU2010215304B2 (da) |
| BR (1) | BRPI1008044A8 (da) |
| CA (1) | CA2753172A1 (da) |
| DK (1) | DK2398818T3 (da) |
| ES (1) | ES2700225T3 (da) |
| FR (1) | FR2942233B1 (da) |
| IL (1) | IL214567A (da) |
| PL (1) | PL2398818T3 (da) |
| WO (1) | WO2010094901A1 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2948664B1 (fr) * | 2009-07-31 | 2013-11-01 | Lfb Biotechnologies | Procede pour la purification de proteines de la coagulation a domaine gla |
| FR2948665B1 (fr) * | 2009-07-31 | 2011-09-23 | Lfb Biotechnologies | Procede pour la purification de proteines de la coagulation a domaine gla actives |
| FR2983212A1 (fr) * | 2011-11-28 | 2013-05-31 | Lfb Biotechnologies | Aptameres anti-fh, procede pour leur obtention et utilisations |
| EP2687595B1 (en) | 2012-07-19 | 2018-05-30 | Laboratoire Français du Fractionnement et des Biotechnologies | Method for purifying transgenic factor VII |
| EP2904005A1 (en) * | 2012-10-03 | 2015-08-12 | CSL Behring LLC | A method of purifying proteins |
| US9534029B2 (en) | 2012-10-03 | 2017-01-03 | Csl Behring Ag | Method of purifying proteins |
| CA2897336C (en) | 2013-01-20 | 2023-10-17 | Dyax Corp. | Evaluation and treatment of pkal-mediated disorders |
| CA2909139C (en) | 2013-04-18 | 2021-07-06 | Institut National De La Sante Et De La Recherche Medicale | Composition with reduced immunogenicity |
| EP2821076A1 (en) | 2013-07-02 | 2015-01-07 | Stallergenes Sa | C1q as a therapeutic agent of allergy and/or asthma |
| PL3060582T3 (pl) | 2013-10-21 | 2021-05-04 | Dyax Corp. | Testy do oznaczania biomarkerów układu kalikreiny osoczowej |
| WO2015066080A2 (en) * | 2013-10-28 | 2015-05-07 | The Regents Of The University Of California | Lipid co-factor essential for cell density signaling |
| FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
| EP2974741A1 (en) | 2014-07-16 | 2016-01-20 | Stallergenes | Composition of allergen extracts having reduced toxicity and method of production thereof |
| CN107001449A (zh) | 2014-10-15 | 2017-08-01 | 芝诺锡拉公司 | 具有降低的免疫原性的组合物 |
| GB201506113D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| GB201506117D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| JP6903648B2 (ja) * | 2015-10-19 | 2021-07-14 | ダイアックス コーポレーション | 切断高分子量キニノーゲンを検出するイムノアッセイ |
| CA3031390A1 (en) * | 2016-07-28 | 2018-02-01 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Anti- immunoglobulin g aptamers and uses thereof |
| CN106148465B (zh) * | 2016-08-09 | 2020-02-14 | 广东海洋大学 | 一种具有抗氧化活性的鲎血浆蛋白水解肽及其制备方法和应用 |
| CN112867729A (zh) * | 2018-10-17 | 2021-05-28 | 德国杰特贝林生物制品有限公司 | 用于纯化c1-inh的方法 |
| CN113795515A (zh) | 2019-04-30 | 2021-12-14 | 芝诺锡拉公司 | 用于治疗癌症的多克隆抗体和抗pd1或抗pdl1抗体的联合 |
| GB201906595D0 (en) * | 2019-05-10 | 2019-06-26 | Ge Healthcare Bioprocess R&D Ab | Method for purification of plasma proteins |
| CN111000974B (zh) * | 2020-02-24 | 2021-07-27 | 重庆大学 | 一种兔奶活性小肽溶液及其提取方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3508149B2 (ja) * | 1993-02-25 | 2004-03-22 | 三菱ウェルファーマ株式会社 | ヒト血清アルブミンおよびその製造方法 |
| JP2869417B2 (ja) * | 1992-09-22 | 1999-03-10 | 吉富製薬株式会社 | 遺伝子操作により得られるヒト血清アルブミン |
| US5521287A (en) * | 1992-05-20 | 1996-05-28 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| US5440018A (en) | 1992-05-20 | 1995-08-08 | The Green Cross Corporation | Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| CA2116385A1 (en) | 1993-02-25 | 1994-08-26 | Akinori Sumi | Human serum albumin and process for producing the same |
| US6117996A (en) * | 1995-09-20 | 2000-09-12 | Novo Nordisk A/S | Triazine based ligands and use thereof |
| EP1330544A4 (en) * | 2000-09-26 | 2005-04-06 | Univ Duke | RNA APTAMERS AND METHOD OF IDENTIFYING SAID APTAMERS |
| MX2007002085A (es) * | 2004-08-20 | 2007-07-19 | Prometic Biosciences Ltd | Esquemas de aislamiento y purificacion consecutivos de proteinas mediante cromatografia de afinidad. |
| AU2006292524A1 (en) * | 2005-09-15 | 2007-03-29 | Duke University | Focused libraries, functional profiling, laser selex and deselex |
| WO2007058592A1 (en) * | 2005-11-21 | 2007-05-24 | Ge Healthcare Bio-Sciences Ab | A method of chromatography using semi-synthetic heparin ligands |
| FR2910786B1 (fr) * | 2006-12-29 | 2017-08-11 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) | "procede d'extraction d'une proteine presente dans du lait" |
-
2009
- 2009-02-19 FR FR0951083A patent/FR2942233B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-19 EP EP10709893.1A patent/EP2398818B1/fr active Active
- 2010-02-19 WO PCT/FR2010/050294 patent/WO2010094901A1/fr active Application Filing
- 2010-02-19 DK DK10709893.1T patent/DK2398818T3/da active
- 2010-02-19 ES ES10709893T patent/ES2700225T3/es active Active
- 2010-02-19 AU AU2010215304A patent/AU2010215304B2/en not_active Ceased
- 2010-02-19 PL PL10709893T patent/PL2398818T3/pl unknown
- 2010-02-19 US US13/201,690 patent/US9534012B2/en active Active
- 2010-02-19 CN CN201080017044.5A patent/CN102405228B/zh not_active Expired - Fee Related
- 2010-02-19 KR KR1020117019398A patent/KR101713761B1/ko active IP Right Grant
- 2010-02-19 BR BRPI1008044A patent/BRPI1008044A8/pt not_active IP Right Cessation
- 2010-02-19 JP JP2011550637A patent/JP6129473B2/ja active Active
- 2010-02-19 CA CA2753172A patent/CA2753172A1/fr not_active Abandoned
-
2011
- 2011-08-09 IL IL214567A patent/IL214567A/en not_active IP Right Cessation
-
2015
- 2015-08-05 JP JP2015154743A patent/JP2016028027A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20120122179A1 (en) | 2012-05-17 |
| EP2398818A1 (fr) | 2011-12-28 |
| IL214567A0 (en) | 2011-09-27 |
| BRPI1008044A2 (pt) | 2016-05-03 |
| WO2010094901A1 (fr) | 2010-08-26 |
| US9534012B2 (en) | 2017-01-03 |
| IL214567A (en) | 2016-12-29 |
| FR2942233A1 (fr) | 2010-08-20 |
| CN102405228A (zh) | 2012-04-04 |
| AU2010215304B2 (en) | 2015-08-13 |
| PL2398818T3 (pl) | 2019-02-28 |
| KR101713761B1 (ko) | 2017-03-08 |
| CA2753172A1 (fr) | 2010-08-26 |
| FR2942233B1 (fr) | 2015-03-13 |
| CN102405228B (zh) | 2016-08-24 |
| AU2010215304A1 (en) | 2011-09-08 |
| EP2398818B1 (fr) | 2018-08-29 |
| BRPI1008044A8 (pt) | 2018-04-03 |
| JP6129473B2 (ja) | 2017-05-17 |
| JP2016028027A (ja) | 2016-02-25 |
| KR20110139199A (ko) | 2011-12-28 |
| ES2700225T3 (es) | 2019-02-14 |
| JP2012518033A (ja) | 2012-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2398818T3 (da) | Midler til oprensning af et blodplasmaprotein og fremgangsmåder til gennemførelse heraf | |
| DK3150240T3 (da) | Systemer og fremgangsmåder til fremføring af terapeutiske midler | |
| DK2414507T3 (da) | Mutanter af aktiveringsinduceret cytidin-deaminase (aid) og til anvendelsesfremgangsmåder | |
| DK2414542T3 (da) | Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose | |
| DK3494972T3 (da) | Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion | |
| DK3351558T3 (da) | Materiale og fremgangsmåder til behandling eller forebyggelse af her-3-relaterede sygdomme | |
| DK2048941T3 (da) | Fremgangsmåde til opdræt af rovmider | |
| DK2440253T3 (da) | Alkylphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller | |
| DK2401024T3 (da) | Indretninger, systemer og fremgangsmåder til magnetisk understøttet afgivelse af et terapeutisk middel | |
| DK2019825T3 (da) | Inhibitorer af human immundefektvirus-replikation | |
| DK2513135T3 (da) | Fremgangsmåde til oprensning af polypeptider | |
| DK2104737T3 (da) | Funktioner og formål for let-7 mikro-RNAer | |
| DK2694091T3 (da) | Fremgangsmåde til fremstilling af kompakte tale-nukleaser og anvendelse heraf | |
| DK2086642T3 (da) | Dnase til behandling af subfertilitet hos mænd | |
| DK2475372T4 (da) | Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse | |
| DK2480574T3 (da) | Anti-cd33-antistoffer og deres anvendelse til immunotargeting i behandlingen af cd33-associerede sygdomme | |
| DK3318255T3 (da) | Sammensætninger og fremgangsmåder til behandling af slagtilfælde hos en patient på samtidig statin-terapi | |
| DK2061803T4 (da) | Fremgangsmåde til oprensning af fc-holdige proteiner | |
| DK2688557T3 (da) | Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed | |
| DK2513193T3 (da) | Forbedrede blends af polyarylenethere og polyarylensulfider | |
| DK2260873T3 (da) | Pcylering af proteiner | |
| DK2563531T3 (da) | Fremgangsmåde og indretning til fordøjelse af væv | |
| DK2483289T3 (da) | Fremgangsmåder til forebyggelse og fjernelse af trisulfidbindinger | |
| DK2646043T3 (da) | Hidtil ukendte cyclosporinderivater til behandling og forebyggelse af en virusinfektion | |
| DK2598516T3 (da) | Fremgangsmåde til proteinoprensning |